- Home
- CDXS vs FLC Comparison
CDXS vs FLC Comparison
Compare CDXS & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CDXS | FLC |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.4M | 162.4M |
| IPO Year | 2008 | 2003 |
Fundamental Metrics
Financial Performance| Metric | CDXS | FLC |
|---|---|---|
| Price | $1.27 | $15.45 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $6.14 | N/A |
| AVG Volume (30 Days) | ★ 761.6K | 42.6K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $4.97 | N/A |
| Revenue Next Year | $18.69 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $15.33 |
| 52 Week High | $2.98 | $18.09 |
Technical Indicators
Market Signals| Indicator | CDXS | FLC |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 37.20 |
| Support Level | $1.27 | $15.33 |
| Resistance Level | $2.70 | $15.85 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 27.66 | 13.46 |
Price Performance
Historical ComparisonAbout CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.